While working at separate companies, life sciences real estate veterans Scott Nudelman and Sam Johnson kept hearing the same thing from frustrated biopharma clients: we need a comprehensive, one-stop-shop solution to simplify and streamline efforts to expand cGMP and biomanufacturing infrastructure projects.